The use of the Bragg peak of charged particles for medical treatments was first proposed in 1946 by Wilsonl. The greatly enhanced dose deposited at the end of the beam range compared to the entrance dose, and the sharp falloff of dose beyond the beam range and at the edge of the collimated field due to small heavy-ion straggling and multiple scattering lead to very precise localization of the dose delivered to the treatent volume, thus maximizing the sparing of normal tissue. In addition, the enhanced biological effectiveness due to the high LET The treatment area, beam delivery and dosimetry instruments were reported in an earlier paper5 so will only be briefly described. Figure 1 
Wilsonl. The greatly enhanced dose deposited at the end of the beam range compared to the entrance dose, and the sharp falloff of dose beyond the beam range and at the edge of the collimated field due to small heavy-ion straggling and multiple scattering lead to very precise localization of the dose delivered to the treatent volume, thus maximizing the sparing of normal tissue. In addition, the enhanced biological effectiveness due to the high LET (dE/dx) of heavy ions has also pointed to these beams as potentially being a very superior modality for the treatment of cancer. Testing of these ideas became possible when heavy ion beams of adequate energy and intensity became available with the creation of the Bevalac in 1974. 2 During the first years of Bevalac operation the biomedical effort concentrated on radiobiology work, laying the foundation for patient radiotherapy.3 4 A dedicated radiotherapy area was created in 1978, 5 and in 1979 full-scale patient treatment was begun.
As of now over 500 treatments with carbon, neon and argon beams have been delivered to about 50 patients, some as boosts from other modalities and some as complete heavy ion treatments. Up to 12 patients per day have been treated in this facility. Continuing efforts in refining techniques and operating procedures are increasing efficiency and accuracy of treatments, and are contributing to the alleviation of scheduling difficulties caused by the unique requirements of radiotherapy with human patients.
Facilities
The treatment area, beam delivery and dosimetry instruments were reported in an earlier paper5 so will only be briefly described. Figure 1 This collimator, poured from cerrobend to the contours specified by the therapist is located as close to the patient as possible and defines the field shape delivered to the patient.
Control System
Key to smooth operation of the facility is the computer control system. A PDP 11/45 with three 80
Mbyte discs and numerous other peripherals provides the computational power. Dosimetry and other data flow to the computer through a CAMAC system. The control software, designed by S. Shlaer at LBL is a channel- different rates will go through the preparation system in slightly different ways, so that beam intensity distributions will be slightly but significantly different on the various ion chamber elements. During patient treatments, when the range cannot be monitored directly, the proper intensity ratios are checked for and flagged for immediate operator attention if they are out of range.
Patient Treatment
As one can see from the above, considerable effort is devoted to accuracy in treatment delivery and in patient safeguarding. We shall now follow a patient through a daily treatment sequence, illustrated in Figure 3 . First the radiotherapy group enters a prescription file into the control system, establishing parameters for the treatment based on clinical experience and treatment planning data. When the patient is set up and aligned properly in the treatment room, a procedure usually taking 15 to 20 minutes, the console operator initiates the treatment 
